Overview

Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus)

Status:
RECRUITING
Trial end date:
2027-04-27
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy and safety of bepirovirsen compared to placebo in participants with human immunodeficiency virus (HIV)/hepatitis B virus (HBV) co-infection.
Phase:
PHASE2
Details
Lead Sponsor:
GlaxoSmithKline